← All Innate Pharma SA filings

Innate Pharma SA Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
IPHA
Innate Pharma SA
SCHEDULE: AstraZeneca Maintains 8.3% Stake in Innate Pharma
AstraZeneca PLC, through its subsidiary MedImmune Limited, has reaffirmed its 8.3% beneficial ownership in Innate Pharma SA.
NASDAQ
IPHA
Innate Pharma SA
SCHEDULE 13D/A: French State-Backed Entities Adjust Innate Pharma SA Ownership Disclosure Following Share Dilution
Several French state-backed entities, including Bpifrance Participations and Caisse des Dépôts, have updated their Schedule 13D filing for Innate Pharma SA, reflecting a decreased percentage ownership due to an increase in the Issuer's outstanding shares, not through their own transactions.